Agios Pharmaceuticals, Inc. (AGIO)
31.90
-0.02
(-0.06%)
USD |
NASDAQ |
Oct 09, 14:25
Agios Pharmaceuticals 30-Day Average Daily Volume : 1.035M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.035M |
| October 07, 2026 | 992318.4 |
| October 06, 2026 | 961287.5 |
| October 05, 2026 | 939866.9 |
| October 02, 2026 | 932161.4 |
| October 01, 2026 | 936413.3 |
| September 30, 2026 | 935968.5 |
| September 29, 2026 | 923947.9 |
| September 28, 2026 | 942377.0 |
| September 25, 2026 | 934937.0 |
| September 24, 2026 | 933024.0 |
| September 23, 2026 | 919289.4 |
| September 22, 2026 | 925498.4 |
| September 21, 2026 | 922202.6 |
| September 18, 2026 | 939373.1 |
| September 17, 2026 | 926773.8 |
| September 16, 2026 | 925405.8 |
| September 15, 2026 | 932369.4 |
| September 14, 2026 | 926885.0 |
| September 11, 2026 | 970470.6 |
| September 10, 2026 | 1.050M |
| September 09, 2026 | 1.064M |
| September 08, 2026 | 1.058M |
| September 04, 2026 | 1.064M |
| September 03, 2026 | 1.078M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.086M |
| September 01, 2026 | 1.091M |
| August 31, 2026 | 1.173M |
| August 28, 2026 | 1.158M |
| August 27, 2026 | 1.166M |
| August 26, 2026 | 1.157M |
| August 25, 2026 | 1.151M |
| August 24, 2026 | 1.148M |
| August 21, 2026 | 1.151M |
| August 20, 2026 | 1.169M |
| August 19, 2026 | 1.164M |
| August 18, 2026 | 1.161M |
| August 17, 2026 | 1.214M |
| August 14, 2026 | 1.198M |
| August 13, 2026 | 1.187M |
| August 12, 2026 | 1.193M |
| August 11, 2026 | 1.185M |
| August 10, 2026 | 1.180M |
| August 07, 2026 | 1.272M |
| August 06, 2026 | 1.251M |
| August 05, 2026 | 1.246M |
| August 04, 2026 | 1.240M |
| August 03, 2026 | 1.250M |
| July 31, 2026 | 1.285M |
| July 30, 2026 | 1.246M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.086M |
| Biogen, Inc. | 1.014M |
| Insmed, Inc. | 2.478M |
| Alnylam Pharmaceuticals, Inc. | 1.503M |
| Regeneron Pharmaceuticals, Inc. | 720681.1 |